MedTrace Logo

Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker

NCT07266142 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7500

Last updated 2025-12-12

No results posted yet for this study

Summary

The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma and non-melanoma skin cancer.

The main questions it aims to answer are:

* To create a biobank with samples of human body material (HBM): blood (serum/plasma/DNA) and tissue and clinical data of patients with cutaneous melanoma and non-melanoma.
* To support future research questions (after specific approval of the Ethics Committee) by using the biobank (through satellite protocols).

If there is a comparison group: Not applicable (umbrella protocol for collection only).

Participants will:

* Share demographics, medical and surgical history, risk factors.
* Complete Cancer Worry Scale questionnaire.
* Provide biological samples:

* Blood samples (serum, plasma, DNA).
* Tissue samples (residual tissue or additional biopsy if consented).

Conditions

  • Skin Cancer, Non-Melanoma
  • Skin Cancer Melanoma

Interventions

OTHER

Collection of Human Body Material and Clinical Data

Blood sampling (serum, plasma, DNA) Tissue sampling (additional biopsy if consented) Completion of Cancer Worry Scale questionnaire

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-17
Primary Completion
2050-01-31
Completion
2051-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07266142 on ClinicalTrials.gov